Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014–present)

Aiken SG. et al, (2025), Expert Opinion on Therapeutic Patents, 1 - 11

Drug repurposing in amyotrophic lateral sclerosis (ALS)

Carroll E. et al, (2025), Expert Opinion on Drug Discovery, 1 - 18

Tracking E2-specific substrates

Jones HBL. et al, (2025), Nature Chemical Biology

Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2

Li HZ. et al, (2025), Nature Communications, 16

Correction: CD4 T cell contact drives macrophage cell cycle G0-G1 transition.

Mlcochova P. et al, (2025), Signal transduction and targeted therapy, 10

USP4 Auto-Deubiquitylation Promotes Homologous Recombination.

Wijnhoven P. et al, (2025), Molecular cell

CD4 T cell contact drives macrophage cell cycle G0-G1 transition.

Mlcochova P. et al, (2024), Signal transduction and targeted therapy, 9

Identification and characterization of human KALRN mRNA and Kalirin protein isoforms.

Mould AW. et al, (2024), Cerebral cortex (New York, N.Y. : 1991), 34

Phenomics-based Discovery of Novel Orthosteric Choline Kinase Inhibitors.

Bauer LG. et al, (2024), Angewandte Chemie (International ed. in English)

Load More